ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q1 2018. The put-call ratio across all filers is 3.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $406,000 | -24.7% | 2,361 | -46.0% | 0.00% | 0.0% |
Q2 2021 | $539,000 | -72.4% | 4,373 | -69.7% | 0.00% | -66.7% |
Q1 2021 | $1,956,000 | +22.9% | 14,423 | +13.7% | 0.00% | 0.0% |
Q4 2020 | $1,592,000 | +316.8% | 12,687 | +273.6% | 0.00% | +200.0% |
Q3 2020 | $382,000 | -87.2% | 3,396 | -89.1% | 0.00% | -80.0% |
Q2 2020 | $2,977,000 | +23.5% | 31,249 | +16.5% | 0.01% | +25.0% |
Q1 2020 | $2,410,000 | +809.4% | 26,818 | +436.4% | 0.00% | – |
Q4 2019 | $265,000 | -34.2% | 5,000 | -46.0% | 0.00% | – |
Q4 2018 | $403,000 | -0.7% | 9,255 | +30.4% | 0.00% | – |
Q3 2018 | $406,000 | -28.8% | 7,100 | -39.5% | 0.00% | -100.0% |
Q2 2018 | $570,000 | +52.8% | 11,739 | +23.1% | 0.00% | – |
Q1 2018 | $373,000 | -21.3% | 9,537 | -48.6% | 0.00% | -100.0% |
Q4 2016 | $474,000 | -35.9% | 18,568 | -9.1% | 0.00% | 0.0% |
Q3 2016 | $739,000 | +248.6% | 20,427 | +204.9% | 0.00% | – |
Q2 2015 | $212,000 | -16.9% | 6,700 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $255,000 | -65.4% | 6,700 | -64.6% | 0.00% | -50.0% |
Q4 2014 | $736,000 | -79.7% | 18,900 | -82.0% | 0.00% | -81.8% |
Q1 2014 | $3,623,000 | – | 105,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |